Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J S Rustin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|November 13, 2003
A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanomaS J Strauss, M Marples, M P Napier, et al.
British Journal of Cancer|February 19, 2004
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancerA E Guppy, A E Nelstrop, T Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000I A McNeish, S Strickland, L Holden, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 13, 2018
The management of high-risk gestational trophoblastic tumours (GTT)E S Newlands, M Bower, L Holden, et al.
British Journal of Cancer|April 17, 2003
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic studyG J S Rustin, C Bradley, S Galbraith, et al.
British Journal of Cancer|November 13, 2003
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up studyJ Gaffan, L Holden, E S Newlands, et al.
British Journal of Cancer|July 7, 2005
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trialG M Mead, M H Cullen, R Huddart, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useM J Duffy, J M Bonfrer, J Kulpa, et al.
Gynecologic Oncology|December 3, 2005
Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG studyM L Harrison, P Hoskins, A du Bois, et al.
British Journal of Cancer|October 20, 2005
Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRIK J Lankester, N J Taylor, J J Stirling, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 13, 2003
A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanomaS J Strauss, M Marples, M P Napier, et al.
British Journal of Cancer|February 19, 2004
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancerA E Guppy, A E Nelstrop, T Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000I A McNeish, S Strickland, L Holden, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 13, 2018
The management of high-risk gestational trophoblastic tumours (GTT)E S Newlands, M Bower, L Holden, et al.
British Journal of Cancer|April 17, 2003
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic studyG J S Rustin, C Bradley, S Galbraith, et al.
British Journal of Cancer|November 13, 2003
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up studyJ Gaffan, L Holden, E S Newlands, et al.
British Journal of Cancer|July 7, 2005
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trialG M Mead, M H Cullen, R Huddart, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useM J Duffy, J M Bonfrer, J Kulpa, et al.
Gynecologic Oncology|December 3, 2005
Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG studyM L Harrison, P Hoskins, A du Bois, et al.
British Journal of Cancer|October 20, 2005
Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRIK J Lankester, N J Taylor, J J Stirling, et al.
Pageof 3